Table of Content

1 INTRODUCTION (Page No. - 30)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 RESEARCH LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
    1.8 IMPACT OF ECONOMIC RECESSION ON MARKET 
2 RESEARCH METHODOLOGY (Page No. - 34)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 3D CELL CULTURE INDUSTRY SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2022
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
          FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
           2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH RATE ASSUMPTIONS 
          FIGURE 8 MARKET: CAGR PROJECTIONS, 2023–2028
          FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 IMPACT OF ECONOMIC RECESSION ON MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 11 3D CELL CULTURE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 3D CELL CULTURE INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF 3D CELL CULTURE INDUSTRY
4 PREMIUM INSIGHTS (Page No. - 49)
    4.1 3D CELL CULTURE MARKET OVERVIEW 
          FIGURE 15 INCREASED FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO PROPEL MARKET
    4.2 NORTH AMERICA: 3D CELL CULTURE INDUSTRY, BY PRODUCT AND COUNTRY (2022) 
          FIGURE 16 SCAFFOLD-BASED 3D CELL CULTURES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 MARKET SHARE, BY APPLICATION, 2023 VS. 2028 
          FIGURE 17 CANCER & STEM CELL RESEARCH TO DOMINATE MARKET IN 2028
    4.4 MARKET SHARE, BY END USER, 2022 (USD MILLION) 
          FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED MARKET IN 2022
    4.5 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028
5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 20 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 3D CELL CULTURE INDUSTRY: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 High focus on developing alternatives to animal testing
                    5.2.1.2 Greater adoption of personalized medicine globally for multiple diseases
                    5.2.1.3 Increased government support and funding for 3D cell culture
                    5.2.1.4 Increased industry-academia collaboration on 3D cell culture and research
           5.2.2 RESTRAINTS
                    5.2.2.1 High costs of implementing 3D cell culture technologies
                    5.2.2.2 Lack of widely accepted or single standardization in 3D cell culture
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emergence of microfluidics-based 3D cell culture
                    5.2.3.2 High growth opportunities and booming biopharmaceutical sector in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of consistency in 3D cell culture products
                    5.2.4.2 High dependence on plastic waste disposals and consumables
                                TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
    5.3 RANGES/SCENARIOS 
          FIGURE 21 SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF MARKET
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 22 VALUE CHAIN ANALYSIS OF MARKET: RAW MATERIAL AND MANUFACTURING PHASE ADD MAXIMUM VALUE
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 23 MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 24 ECOSYSTEM ANALYSIS: MARKET
          TABLE 6 MARKET: ROLE IN ECOSYSTEM
    5.8 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 7 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 PATENT ANALYSIS 
           5.9.1 LIST OF MAJOR PATENTS
    5.10 PRICING ANALYSIS 
           TABLE 8 SELLING PRICE OF 3D CELL CULTURE PRODUCTS BY TOP PLAYERS (2022)
           TABLE 9 AVERAGE SELLING PRICE, BY APPLICATION (2022)
    5.11 TECHNOLOGY ANALYSIS 
           TABLE 10 ADVANTAGES AND DISADVANTAGES OF 3D CELL CULTURE TECHNIQUES
    5.12 REGULATORY ANALYSIS 
           5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 KEY CONFERENCES AND EVENTS IN 2023 
           TABLE 15 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF 3D CELL CULTURE PRODUCTS
           5.14.2 BUYING CRITERIA
                     FIGURE 26 KEY BUYING CRITERIA FOR END USERS
6 3D CELL CULTURE MARKET, BY PRODUCT (Page No. - 77)
    6.1 INTRODUCTION 
          TABLE 16 3D CELL CULTURE INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 SCAFFOLD-BASED 3D CELL CULTURES 
          TABLE 17 MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 18 MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 19 NORTH AMERICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 20 EUROPE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 21 ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 HYDROGELS/ECM ANALOGS
                    6.2.1.1 Hydrogels/ECM analogs to dominate scaffold-based 3D cell cultures market during forecast period
                                TABLE 22 HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 23 NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 24 EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 25 ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 NATURAL & SYNTHETIC HYDROGELS
                    6.2.2.1 Easy synthetization on large scale and improved control of matrix architecture to propel segment
                                TABLE 26 HYDROGELS/ECM ANALOGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.2.3 SOLID SCAFFOLDS
                    6.2.3.1 Solid scaffolds to be widely adopted in regenerative medicine and preclinical in-vitro testing
                                TABLE 27 SOLID SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 28 NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 29 EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 30 ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 MICROPATTERNED SURFACES
                    6.2.4.1 Micropatterned surfaces to enhance expression of enzyme levels and drug reactivity
                                TABLE 31 MICROPATTERNED SURFACES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 32 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 33 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 34 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 SCAFFOLD-FREE 3D CELL CULTURES 
          TABLE 35 MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 36 MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 37 NORTH AMERICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 38 EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 39 ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 LOW ATTACHMENT PLATES
                    6.3.1.1 Low attachment plates to grow at highest rate in scaffold-free 3D cell cultures market
                                TABLE 40 LOW ATTACHMENT PLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 41 NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 42 EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 43 ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 HANGING DROP PLATES
                    6.3.2.1 Hanging drop plates to be mostly used in stem cell differentiation and cytotoxicity research
                                TABLE 44 HANGING DROP PLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 45 NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 46 EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 47 ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 3D BIOREACTORS
                    6.3.3.1 3D bioreactors to be commonly used in mass production of cells
                                TABLE 48 3D BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 49 NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 50 EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 51 ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 3D PETRI DISHES
                    6.3.4.1 Europe to witness highest growth in 3D Petri dishes during study period
                                TABLE 52 3D PETRI DISHES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 53 NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 54 EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 55 ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 MICROFLUIDICS-BASED 3D CELL CULTURES 
           6.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
                    TABLE 56 MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 57 NORTH AMERICA: MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 58 EUROPE: MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 59 ASIA PACIFIC: MARKET FOR 3D MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
    6.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES 
           6.5.1 3D CELL CULTURE TO BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION
                    TABLE 60 MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 61 NORTH AMERICA: MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 EUROPE: MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 63 ASIA PACIFIC: MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
7 3D CELL CULTURE MARKET, BY END USER (Page No. - 104)
    7.1 INTRODUCTION 
          TABLE 64 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           7.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS OF 3D CELL CULTURE PRODUCTS
                    TABLE 65 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 66 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 67 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 68 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 RESEARCH INSTITUTES 
           7.3.1 INCREASED GOVERNMENT FUNDING FOR RESEARCH AND HIGH PREVALENCE OF CANCER TO AUGMENT MARKET
                    TABLE 69 MARKET FOR RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 70 NORTH AMERICA: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 71 EUROPE: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 72 ASIA PACIFIC: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 COSMETICS INDUSTRY 
           7.4.1 FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET
                    TABLE 73 MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 74 NORTH AMERICA: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 75 EUROPE: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 76 ASIA PACIFIC: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 OTHER END USERS 
          TABLE 77 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 78 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 79 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 80 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
8 3D CELL CULTURE MARKET, BY APPLICATION (Page No. - 115)
    8.1 INTRODUCTION 
          TABLE 81 MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.2 CANCER & STEM CELL RESEARCH 
           8.2.1 RISING PREVALENCE OF CANCER AND OTHER COMPLEX DISEASES GLOBALLY TO PROPEL MARKET
                    TABLE 82 MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 83 NORTH AMERICA: MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 84 EUROPE: MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 85 ASIA PACIFIC: MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 DRUG DISCOVERY & TOXICOLOGY TESTING 
           8.3.1 INCREASED ADOPTION OF PERSONALIZED MEDICINES AND EXPANSION OF PHARMACEUTICAL COMPANIES TO SUPPORT MARKET
                    TABLE 86 MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 87 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 88 EUROPE: MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 
           8.4.1 INCREASING RESEARCH ON 3D CULTURE TECHNIQUES TO AID MARKET
                    TABLE 90 MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 91 NORTH AMERICA: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 92 EUROPE: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 93 ASIA PACIFIC: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
9 3D CELL CULTURE MARKET, BY REGION (Page No. - 124)
    9.1 INTRODUCTION 
          TABLE 94 3D CELL CULTURE INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 27 NORTH AMERICA: MARKET SNAPSHOT
          TABLE 95 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 96 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 97 NORTH AMERICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 98 NORTH AMERICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 99 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 100 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Adoption of innovative techniques and government-funded initiatives to drive market
                                TABLE 101 US: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 102 US: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 103 US: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 104 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 105 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Advancements in regenerative medicine to boost market
                                TABLE 106 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 107 CANADA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 108 CANADA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 109 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 110 CANADA: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.2.3 NORTH AMERICA: RECESSION IMPACT
    9.3 EUROPE 
          TABLE 111 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 112 EUROPE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 113 EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 114 EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 115 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 116 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Spike in investments by key players and growing funding from government organizations to fuel market
                                TABLE 117 GERMANY: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 118 GERMANY: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 119 GERMANY: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 120 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 121 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Growth in life sciences industry to drive market
                                TABLE 122 UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 123 UK: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 124 UK: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 125 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 126 UK: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Growth in biotechnology industry to propel market
                                TABLE 127 FRANCE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 128 FRANCE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 129 FRANCE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 130 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 131 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increase in research activities and funds to boost market
                                TABLE 132 ITALY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 133 ITALY: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 134 ITALY: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 135 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 136 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increased collaborations in research and focus on personalized medicine to drive market
                                TABLE 137 SPAIN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 138 SPAIN: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 139 SPAIN: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 140 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 141 SPAIN: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 142 REST OF EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 143 REST OF EUROPE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 144 REST OF EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 145 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 146 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.7 EUROPE: RECESSION IMPACT
    9.4 ASIA PACIFIC 
          FIGURE 28 ASIA PACIFIC: MARKET SNAPSHOT
          TABLE 147 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 148 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 149 ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 150 ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 151 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 152 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Government support and strategic initiatives by key players to strengthen use of biotechnology
                                TABLE 153 CHINA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 154 CHINA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 155 CHINA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 156 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 157 CHINA: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Rising prevalence of cancer and increased adoption of 3D cell culture to augment market growth
                                TABLE 158 JAPAN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 159 JAPAN: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 160 JAPAN: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 161 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 162 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Growth in life sciences industry to support market
                                TABLE 163 INDIA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 164 INDIA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 165 INDIA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 166 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 167 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 168 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           9.4.5 ASIA PACIFIC: RECESSION IMPACT
                    TABLE 169 REST OF ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 170 REST OF ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 171 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 172 REST OF ASIA PACIFIC: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 GROWING GOVERNMENT INVESTMENTS AND AVAILABILITY OF GRANTS FOR CELL-BASED RESEARCH TO DRIVE MARKET
                    TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 174 LATIN AMERICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 175 LATIN AMERICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 176 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 177 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.2 LATIN AMERICA: RECESSION IMPACT
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 INCREASED FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN RESEARCH TO AID MARKET
                    TABLE 178 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 179 MIDDLE EAST & AFRICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 180 MIDDLE EAST & AFRICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 181 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 182 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE (Page No. - 180)
     10.1 INTRODUCTION 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 29 3D CELL CULTURE MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     10.3 REVENUE SHARE ANALYSIS 
             FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 31 MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
             TABLE 183 MARKET: DEGREE OF COMPETITION
     10.5 COMPANY EVALUATION QUADRANT 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 32 MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
     10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 184 MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
             10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 185 MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
     10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 STARTING BLOCKS
             10.7.3 RESPONSIVE COMPANIES
             10.7.4 DYNAMIC COMPANIES
                        FIGURE 33 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 
             TABLE 186 MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
             TABLE 187 MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
     10.9 COMPETITIVE SCENARIOS AND TRENDS 
             10.9.1 PRODUCT LAUNCHES
                        TABLE 188 MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023
             10.9.2 DEALS
                        TABLE 189 MARKET: DEALS, JANUARY 2020–APRIL 2023
             10.9.3 OTHER DEVELOPMENTS
                        TABLE 190 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023
11 COMPANY PROFILES (Page No. - 195)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 191 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
                        FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
             11.1.2 MERCK KGAA
                        TABLE 192 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
             11.1.3 CORNING INCORPORATED
                        TABLE 193 CORNING INCORPORATED: COMPANY OVERVIEW
                        FIGURE 36 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
             11.1.4 LONZA
                        TABLE 194 LONZA: COMPANY OVERVIEW
                        FIGURE 37 LONZA: COMPANY SNAPSHOT (2022)
             11.1.5 TECAN TRADING AG
                        TABLE 195 TECAN TRADING AG: COMPANY OVERVIEW
                        FIGURE 38 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
             11.1.6 AVANTOR, INC.
                        TABLE 196 AVANTOR, INC.: COMPANY OVERVIEW
                        FIGURE 39 AVANTOR, INC: COMPANY SNAPSHOT (2022)
             11.1.7 REPROCELL INC.
                        TABLE 197 REPROCELL: COMPANY OVERVIEW
             11.1.8 3D BIOTEK LLC
                        TABLE 198 3D BIOTEK LLC: COMPANY OVERVIEW
             11.1.9 EMULATE, INC.
                        TABLE 199 EMULATE, INC.: COMPANY OVERVIEW
             11.1.10 SYNTHECON, INCORPORATED
                        TABLE 200 SYNTHECON, INCORPORATED: COMPANY OVERVIEW
             11.1.11 INSPHERO AG
                        TABLE 201 INSPHERO AG: COMPANY OVERVIEW
             11.1.12 KIRKSTALL LTD.
                        TABLE 202 KIRKSTALL LTD.: COMPANY OVERVIEW
             11.1.13 GREINER BIO-ONE INTERNATIONAL GMBH
                        TABLE 203 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW
             11.1.14 PROMOCELL GMBH
                        TABLE 204 PROMOCELL GMBH: COMPANY OVERVIEW
             11.1.15 UPM BIOMEDICALS
                        TABLE 205 UPM: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS 
             11.2.1 CN BIO INNOVATIONS LTD.
             11.2.2 TISSUSE GMBH
             11.2.3 LENA BIOSCIENCES INC.
             11.2.4 CELLENDES GMBH
             11.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO)
             11.2.6 SYNVIVO INC.
             11.2.7 AMSBIO
             11.2.8 MIMETAS BV
             11.2.9 S-BIO, VAUPELL HOLDINGS INC. (A GROUP COMPANY OF SUMITOMO BAKELITE CO., LTD.)
             11.2.10 NANOFIBER SOLUTIONS
12 APPENDIX (Page No. - 238)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS